Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells

Udit N. Verma, Rama M. Surabhi, Aurelia Schmaltieg, Carlos Becerra, Richard B. Gaynor

Research output: Contribution to journalArticle

294 Citations (Scopus)

Abstract

The β-catenin and APC genes are key components of the Wnt signaling pathway. Mutation of these genes results in increased levels of the β-catenin protein, which is associated with enhanced cellular proliferation and the development of both colon polyps and colon cancer. Recently, a technique known as RNA interference has been successfully adapted to mammalian cells so that it is now possible to specifically decrease the expression of cellular genes after transfection of annealed small interfering 21-mer RNAs. In the current study, we used small interfering RNA (siRNA) directed against β-catenin to determine the effects of decreasing the high constitutive levels of this protein in colon cancer cell lines with mutations in either β-catenin or APC. Our studies demonstrate that siRNA directed against β-catenin markedly decreased β-catenin-dependent gene expression and inhibited cellular proliferation as reflected in the reduced growth of these colon cancer cells both in soft agar and in nude mice. These results indicate that siRNA can target specific factors whose expression is altered in malignancy and may have the potential as a therapeutic modality to treat human cancer.

Original languageEnglish (US)
Pages (from-to)1291-1300
Number of pages10
JournalClinical Cancer Research
Volume9
Issue number4
StatePublished - Apr 1 2003

Fingerprint

Catenins
Colonic Neoplasms
Small Interfering RNA
Growth
Cell Proliferation
APC Genes
Gene Components
Gene Expression
Mutation
Wnt Signaling Pathway
RNA Interference
Polyps
Nude Mice
Agar
Transfection
In Vitro Techniques
Neoplasms
Colon
RNA
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. / Verma, Udit N.; Surabhi, Rama M.; Schmaltieg, Aurelia; Becerra, Carlos; Gaynor, Richard B.

In: Clinical Cancer Research, Vol. 9, No. 4, 01.04.2003, p. 1291-1300.

Research output: Contribution to journalArticle

Verma, Udit N. ; Surabhi, Rama M. ; Schmaltieg, Aurelia ; Becerra, Carlos ; Gaynor, Richard B. / Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. In: Clinical Cancer Research. 2003 ; Vol. 9, No. 4. pp. 1291-1300.
@article{7ee15b71773c4950998388c2d4f8286b,
title = "Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells",
abstract = "The β-catenin and APC genes are key components of the Wnt signaling pathway. Mutation of these genes results in increased levels of the β-catenin protein, which is associated with enhanced cellular proliferation and the development of both colon polyps and colon cancer. Recently, a technique known as RNA interference has been successfully adapted to mammalian cells so that it is now possible to specifically decrease the expression of cellular genes after transfection of annealed small interfering 21-mer RNAs. In the current study, we used small interfering RNA (siRNA) directed against β-catenin to determine the effects of decreasing the high constitutive levels of this protein in colon cancer cell lines with mutations in either β-catenin or APC. Our studies demonstrate that siRNA directed against β-catenin markedly decreased β-catenin-dependent gene expression and inhibited cellular proliferation as reflected in the reduced growth of these colon cancer cells both in soft agar and in nude mice. These results indicate that siRNA can target specific factors whose expression is altered in malignancy and may have the potential as a therapeutic modality to treat human cancer.",
author = "Verma, {Udit N.} and Surabhi, {Rama M.} and Aurelia Schmaltieg and Carlos Becerra and Gaynor, {Richard B.}",
year = "2003",
month = "4",
day = "1",
language = "English (US)",
volume = "9",
pages = "1291--1300",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells

AU - Verma, Udit N.

AU - Surabhi, Rama M.

AU - Schmaltieg, Aurelia

AU - Becerra, Carlos

AU - Gaynor, Richard B.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - The β-catenin and APC genes are key components of the Wnt signaling pathway. Mutation of these genes results in increased levels of the β-catenin protein, which is associated with enhanced cellular proliferation and the development of both colon polyps and colon cancer. Recently, a technique known as RNA interference has been successfully adapted to mammalian cells so that it is now possible to specifically decrease the expression of cellular genes after transfection of annealed small interfering 21-mer RNAs. In the current study, we used small interfering RNA (siRNA) directed against β-catenin to determine the effects of decreasing the high constitutive levels of this protein in colon cancer cell lines with mutations in either β-catenin or APC. Our studies demonstrate that siRNA directed against β-catenin markedly decreased β-catenin-dependent gene expression and inhibited cellular proliferation as reflected in the reduced growth of these colon cancer cells both in soft agar and in nude mice. These results indicate that siRNA can target specific factors whose expression is altered in malignancy and may have the potential as a therapeutic modality to treat human cancer.

AB - The β-catenin and APC genes are key components of the Wnt signaling pathway. Mutation of these genes results in increased levels of the β-catenin protein, which is associated with enhanced cellular proliferation and the development of both colon polyps and colon cancer. Recently, a technique known as RNA interference has been successfully adapted to mammalian cells so that it is now possible to specifically decrease the expression of cellular genes after transfection of annealed small interfering 21-mer RNAs. In the current study, we used small interfering RNA (siRNA) directed against β-catenin to determine the effects of decreasing the high constitutive levels of this protein in colon cancer cell lines with mutations in either β-catenin or APC. Our studies demonstrate that siRNA directed against β-catenin markedly decreased β-catenin-dependent gene expression and inhibited cellular proliferation as reflected in the reduced growth of these colon cancer cells both in soft agar and in nude mice. These results indicate that siRNA can target specific factors whose expression is altered in malignancy and may have the potential as a therapeutic modality to treat human cancer.

UR - http://www.scopus.com/inward/record.url?scp=0037388638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037388638&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 1291

EP - 1300

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 4

ER -